Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Serum Zinc Level and non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases.

Nishikawa H, Takata R, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2020 Jan 17;9(1). pii: E255. doi: 10.3390/jcm9010255.

2.

Walking Speed: Japanese Data in Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2020 Jan 7;9(1). pii: E166. doi: 10.3390/jcm9010166.

3.

Impact of Sustained Virological Response for Gastroesophageal Varices in Hepatitis-C-Virus-Related Liver Cirrhosis.

Yuri Y, Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Dec 30;9(1). pii: E95. doi: 10.3390/jcm9010095.

4.

Serum zinc concentration and quality of life in chronic liver diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

Medicine (Baltimore). 2020 Jan;99(1):e18632. doi: 10.1097/MD.0000000000018632.

5.

Combined albumin-bilirubin grade and Mac-2 binding protein glycosylation isomer as a useful predictor in compensated liver cirrhosis.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

Medicine (Baltimore). 2019 Dec;98(50):e18366. doi: 10.1097/MD.0000000000018366.

6.

Serum Zinc Level Classification System: Usefulness in Patients with Liver Cirrhosis.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Nov 22;8(12). pii: E2057. doi: 10.3390/jcm8122057.

7.

Association between Albumin-Bilirubin Grade and Non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases.

Takata R, Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Sep 18;8(9). pii: E1485. doi: 10.3390/jcm8091485.

8.

Significant Correlation Between Grip Strength and m2bpgi in Patients with Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Sep 1;8(9). pii: E1359. doi: 10.3390/jcm8091359.

9.

Combined Albumin-Bilirubin Grade and Skeletal Muscle Mass as a Predictor in Liver Cirrhosis.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Jun 1;8(6). pii: E782. doi: 10.3390/jcm8060782.

10.

Association between Sarcopenia and Depression in Patients with Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 May 8;8(5). pii: E634. doi: 10.3390/jcm8050634.

11.

Serum Zinc Concentration and Sarcopenia: A Close Linkage in Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Mar 11;8(3). pii: E336. doi: 10.3390/jcm8030336.

12.

Effect of Sarcopenia on Sleep Disturbance in Patients with Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2018 Dec 22;8(1). pii: E16. doi: 10.3390/jcm8010016.

13.

Health-Related Quality of Life in Chronic Liver Diseases: A Strong Impact of Hand Grip Strength.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2018 Dec 15;7(12). pii: E553. doi: 10.3390/jcm7120553.

14.

Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis.

Nishikawa H, Enomoto H, Iwata Y, Kishino K, Shimono Y, Hasegawa K, Nakano C, Takata R, Ishii A, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

Medicine (Baltimore). 2017 Jan;96(3):e5800. doi: 10.1097/MD.0000000000005800.

15.

Effect of L-Carnitine in Patients With Liver Cirrhosis on Energy Metabolism Using Indirect Calorimetry: A Pilot Study.

Sakai Y, Nishikawa H, Enomoto H, Yoh K, Iwata Y, Hasegawa K, Nakano C, Kishino K, Shimono Y, Takata R, Nishimura T, Aizawa N, Ikeda N, Takashima T, Ishii A, Iijima H, Nishiguchi S.

J Clin Med Res. 2016 Dec;8(12):863-869. Epub 2016 Oct 26.

16.

A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation.

Nishikawa H, Hasegawa K, Ishii A, Takata R, Enomoto H, Yoh K, Kishino K, Shimono Y, Iwata Y, Nakano C, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

Medicine (Baltimore). 2016 Aug;95(35):e4679. doi: 10.1097/MD.0000000000004679.

17.

Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Hasegawa K, Nakano C, Takata R, Kishino K, Shimono Y, Sakai Y, Nishimura T, Aizawa N, Ikeda N, Takashima T, Ishii A, Iijima H, Nishiguchi S.

Medicine (Baltimore). 2016 Jun;95(24):e3920. doi: 10.1097/MD.0000000000003920. Erratum in: Medicine (Baltimore). 2016 Aug 07;95(31):e5074.

18.

Prediction of development of hepatocellular carcinoma using a new scoring system involving virtual touch quantification in patients with chronic liver diseases.

Aoki T, Iijima H, Tada T, Kumada T, Nishimura T, Nakano C, Kishino K, Shimono Y, Yoh K, Takata R, Ishii A, Takashima T, Sakai Y, Aizawa N, Nishikawa H, Ikeda N, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S.

J Gastroenterol. 2017 Jan;52(1):104-112. doi: 10.1007/s00535-016-1228-7. Epub 2016 Jun 15.

PMID:
27306373
19.

Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin-positive Mac-2-binding protein in chronic hepatitis C.

Nishikawa H, Takata R, Enomoto H, Yoh K, Kishino K, Shimono Y, Iwata Y, Hasegawa K, Nakano C, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Ishii A, Iijima H, Nishiguchi S.

Hepatol Res. 2017 Mar;47(3):E74-E84. doi: 10.1111/hepr.12724. Epub 2016 May 26.

PMID:
27075409
20.

B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Interferon-γ-Inducible Protein-10 in Autoimmune Hepatitis.

Nishikawa H, Enomoto H, Iwata Y, Kishino K, Shimono Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Yoh K, Ishii A, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

Medicine (Baltimore). 2016 Mar;95(12):e3194. doi: 10.1097/MD.0000000000003194.

Supplemental Content

Loading ...
Support Center